Abrocitinib versus dupilumab: impact on skin barrier function and proteomics in atopic dermatitis [0.03%]
阿布司替尼与杜匹尔单抗对特应性皮炎皮肤屏障功能及蛋白质组学的影响
Jui-Wen Chang,Xiaobao Huang,Wenjing Jiang et al.
Jui-Wen Chang et al.
Background: The comparative impact of dupilumab and abrocitinib on skin barrier function and associated proteomics in atopic dermatitis (AD) remains not fully identified. ...
Efficacy following discontinuation of sonidegib 200 mg daily treatment in patients with locally advanced basal cell carcinoma: Post hoc analysis of the 42-month BOLT study [0.03%]
一项事后分析：在局部晚期基底细胞癌患者中，接受索立德吉每日200毫克治疗后停药的疗效——BOLT研究42个月的数据
Michael R Migden,Meenal Kheterpal,Brent Moody et al.
Michael R Migden et al.
Response to Michelerio et al. regarding "Antibody-drug conjugates: A review of cutaneous adverse effects" [0.03%]
关于“抗体-药物偶联物：皮肤不良反应综述”的评论答复
Debby Cheng,Shahin A Saberi,Vinod E Nambudiri
Debby Cheng
When a post costs more than likes: social media misconduct in dermatology [0.03%]
当发帖的成本超过点赞量：皮肤科的社交媒体不当行为
Rahib K Islam,Shari R Lipner
Rahib K Islam
National opioid prescription decline across outpatient specialty surgeries: a claims database study [0.03%]
美国门诊专科手术中阿片类药物处方的下降趋势：基于索赔数据库的研究
Surya A Veerabagu,Shannon T Nugent,Zhi Geng et al.
Surya A Veerabagu et al.
Background: The Centers for Disease Control and Prevention (CDC) encourages physicians to limit unnecessary opioid prescriptions. Objective: ...
Response to Saberi SA et al.'s "Antibody-drug conjugates: A review of cutaneous adverse effects" [0.03%]
Saberi SA等人的“抗体-药物偶联物：皮肤不良反应综述”的评论答复
Andrea Michelerio,Carlo Tomasini
Andrea Michelerio
Skincare Ingredients Recommended by Cosmetic Dermatologists: A Delphi Consensus Study [0.03%]
化妆品皮肤科医生推荐的护肤成分：德尔菲共识研究
Gabriella V Alvarez,Bianca Y Kang,Alexandra M Richmond et al.
Gabriella V Alvarez et al.
Background: There is ambiguity regarding the topical cosmetic ingredients preferred for common skin complaints. Objective: To determine...
A Novel Treatment for Refractory Dermatomyositis: A Systematic Review of Anifrolumab and Dermatomyositis [0.03%]
难治性皮肌炎的新型疗法——Anifrolumab治疗皮肌炎的系统评价
Anagha Srivatsa,Wasey Rehman,Rafey Rehman et al.
Anagha Srivatsa et al.
A Technique for Enhanced Tension Control: The Benefits of Presetting Sutures in Wound Closure [0.03%]
改良的张力缝合技术——伤口闭合前的预缝合优点分析
Nicholas S Doss-Hom,Sophia K Levit,Eyal K Levit
Nicholas S Doss-Hom